Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects

NCT02670824 is registered in ClinicalTrials.gov with AegisCN LLC as lead sponsor.

NCT NCT02670824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02670824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects
Lead sponsor
AegisCN LLC
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2015
Completion date
August 31, 2016
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage (ich)